Articles In Press
Back to the articles list |
Back to browse issues page
Amir Hossein Omidi1 
, Reyhaneh Seydmohammadi2 , Mohammad Reza Mohammadi3 , Mina Latifian1 , Vajihe Sadat Nikbin4 , Fereshteh Atabi2 , Reza Hosseini Doust5 , Fereshteh Shahcheraghi *6
, Reyhaneh Seydmohammadi2 , Mohammad Reza Mohammadi3 , Mina Latifian1 , Vajihe Sadat Nikbin4 , Fereshteh Atabi2 , Reza Hosseini Doust5 , Fereshteh Shahcheraghi *6
1- Department of Epidemiology and Biostatics, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran
2- Department of Biochemistry and Biophysics, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
3- Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
4- Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran
5- Department of Microbiology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
6- Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran ,shahcheraghifereshteh@yahoo.com
2- Department of Biochemistry and Biophysics, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
3- Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
4- Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran
5- Department of Microbiology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
6- Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran ,
Abstract: (527 Views)
Background & Objective: Enterobacteriaceae, a family of Gram-negative bacteria in the normal gut flora, are common human pathogens. The rising fecal carriage of carbapenemase-producing (CPE) and extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE) poses significant resistance to beta-lactam antibiotics. Due to this issue, This study focused on the prevalence and molecular characterization of beta-lactamase genes (blaKPC, blaIMP, blaVIM, blaNDM, blaSHV, blaTEM, blaOXA, and blaCTX-M) in Enterobacteriaceae isolates from hospitalized patients in Shahriar, Iran.
Materials & Methods: A total of 85 stool samples were collected from hospitalized patients in the ICU and general wards of Imam Sajjad Hospital, Shahriar. Bacterial isolates were identified using standard microbiological methods for identification of Enterobacteriaceae. Antibiotic susceptibility profile of isolates was analysed by using the disc diffusion, and Minimum inhibitory concentrations (MICs) method based on the Clinical and Laboratory Standards Institute (CLSI) 2023 guidelines. Phenotypic detection of ESBL and such as metallo-beta-lactamase (MBL) resistance, was performed using combined disc tests with specific inhibitors. PCR amplification with specific primer was used for detection beta-lactamase genes including blaKPC, blaIMP, blaVIM, blaNDM, blaSHV, blaTEM, blaOXA and blaCTX-M.
Results: From 85 samples, 19 isolates of Klebsiella pneumoniae (20.43%) and 66 isolates of Escherichia coli (79.57%) were identified. Among these, 31 isolates exhibited ESBL and 10 were identified as MBL. Among the 31 carbapenem-resistant or intermediate isolates, all carried the blaCTX-M gene. Additionally, 2 isolates carried the blaNDM-1 gene, and another 2 harbored the blaIMP gene. However, the blaKPC and blaVIM genes were not detected in any of the isolates.
Conclusion: blaCTX-M gene is one of the most common resistant genes in Iran. According to studies, the prevalence of antibiotic resistance in Iran is rising dramatically, which reduces the choice of antibiotics to treat severe infections in the future.
Materials & Methods: A total of 85 stool samples were collected from hospitalized patients in the ICU and general wards of Imam Sajjad Hospital, Shahriar. Bacterial isolates were identified using standard microbiological methods for identification of Enterobacteriaceae. Antibiotic susceptibility profile of isolates was analysed by using the disc diffusion, and Minimum inhibitory concentrations (MICs) method based on the Clinical and Laboratory Standards Institute (CLSI) 2023 guidelines. Phenotypic detection of ESBL and such as metallo-beta-lactamase (MBL) resistance, was performed using combined disc tests with specific inhibitors. PCR amplification with specific primer was used for detection beta-lactamase genes including blaKPC, blaIMP, blaVIM, blaNDM, blaSHV, blaTEM, blaOXA and blaCTX-M.
Results: From 85 samples, 19 isolates of Klebsiella pneumoniae (20.43%) and 66 isolates of Escherichia coli (79.57%) were identified. Among these, 31 isolates exhibited ESBL and 10 were identified as MBL. Among the 31 carbapenem-resistant or intermediate isolates, all carried the blaCTX-M gene. Additionally, 2 isolates carried the blaNDM-1 gene, and another 2 harbored the blaIMP gene. However, the blaKPC and blaVIM genes were not detected in any of the isolates.
Conclusion: blaCTX-M gene is one of the most common resistant genes in Iran. According to studies, the prevalence of antibiotic resistance in Iran is rising dramatically, which reduces the choice of antibiotics to treat severe infections in the future.
Type of Study: Original Research Article |
Subject:
Clinical Medicine
Received: 2025/01/31 | Accepted: 2026/03/17
Received: 2025/01/31 | Accepted: 2026/03/17
References
1. Horn RV, Cardoso WM, Lopes ES, Teixeira RS, Albuquerque ÁH, Rocha-e-Silva RC, et al. Identification and antimicrobial resistance of members from the Enterobacteriaceae family isolated from canaries (Serinus canaria). Pesquisa Veterinária Brasileira. 2015;35:552-6. [DOI:10.1590/S0100-736X2015000600011]
2. Denton M. Enterobacteriaceae. Int J Antimicrob Agent. 2007;29:S9-S22. [DOI:10.1016/S0924-8579(07)72174-X] [PMID]
3. Nakano S, Kobayashi T, Funabiki K, Matsumura A, Nagao Y, Yamada T. Development of a PCR assay for detection of Enterobacteriaceae in foods. J Food Protect. 2003;66(10):1798-804. [DOI:10.4315/0362-028X-66.10.1798] [PMID]
4. Paterson DL. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Infect Control. 2006;34(5):S20-S8.
5. Pitout JD. Multiresistant Enterobacteriaceae: new threat of an old problem. Expert Rev Anti Infect Ther. 2008;6(5):657-69. [DOI:10.1586/14787210.6.5.657] [PMID]
6. Capita R, Alonso-Calleja C. Antibiotic-resistant bacteria: a challenge for the food industry. Crit Rev Food Sci Nutr. 2013;53(1):11-48. [DOI:10.1080/10408398.2010.519837] [PMID]
7. Meletis G. Carbapenem resistance: overview of the problem and future perspectives. Therap Adv Infect Dis. 2016;3(1):15-21. [DOI:10.1177/2049936115621709] [PMID] [PMCID]
8. Armstrong T, Samuel Jacob F, Kim R. Carbapenems: a broad-spectrum antibiotic. J Med Microbiol. 2021; 70(12) : 001462. [DOI:10.1099/jmm.0.001462] [PMID] [PMCID]
9. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011;17(10):1791. [DOI:10.3201/eid1710.110655] [PMID] [PMCID]
10. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9(4):228-36. [DOI:10.1016/S1473-3099(09)70054-4] [PMID]
11. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agen Chemother. 2001;45(4):1151-61. [DOI:10.1128/AAC.45.4.1151-1161.2001] [PMID] [PMCID]
12. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-β-lactamases: the quiet before the storm? Clin Microb Rev. 2005;18(2):306-25. [DOI:10.1128/CMR.18.2.306-325.2005] [PMID] [PMCID]
13. Poirel L, Héritier C, Tolün V, Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agent Chemother. 2004;48(1):15-22. [DOI:10.1128/AAC.48.1.15-22.2004] [PMID] [PMCID]
14. Zhao Z-c, Xu X-h, Liu M-b, Wu J, Lin J, Li B. Fecal carriage of carbapenem-resistant Enterobacteriaceae in a Chinese university hospital. Am J Infect Control. 2014;42(5):e61-e4. [DOI:10.1016/j.ajic.2014.01.024] [PMID]
15. Bevan ER, Jones AM, Hawkey PM. Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype. J Antimicrob Chemother. 2017;72(8):2145-55. [DOI:10.1093/jac/dkx146] [PMID]
16. Dunn SJ, Connor C, McNally A. The evolution and transmission of multi-drug resistant Escherichia coli and Klebsiella pneumoniae: the complexity of clones and plasmids. Curr Opin Microb. 2019;51:51-6. [DOI:10.1016/j.mib.2019.06.004] [PMID]
17. Shahcheraghi F, Aslani MM, Mahmoudi H, Karimitabar Z, Solgi H, Bahador A,et al. Molecular study of carbapenemase genes in clinical isolates of Enterobacteriaceae resistant to carbapenems and determining their clonal relationship using pulsed-field gel electrophoresis. J Med Microbiol. 2017;66(5):570-6. [DOI:10.1099/jmm.0.000467] [PMID]
18. Control CfD, Prevention. Laboratory protocol for detection of carbapenem-resistant or carbapenemase-producing, Klebsiella spp. and E. coli from rectal swabs. Centers for Disease Control and Prevention, Atlanta GA. 2009.
19. Lewis I, James S. Performance standards for antimicrobial susceptibility testing. 2022.
20. Shoaib M, Muzammil I, Hammad M, Bhutta ZA, Yaseen I. A mini-review on commonly used biochemical tests for identification of bacteria. Int J Res Pub.2020;54(1):8-. [DOI:10.47119/IJRP100541620201224]
21. Bahramian A, Khoshnood S, Hashemi N, Moradi M, Karimi-Yazdi M, Jalallou N, Saki M. Identification of metallo-β-lactamases and AmpC production among Escherichia coli strains isolated from hemodialysis patients with urinary tract infection. Molec Biol Rep. 2021;48:7883-92. [DOI:10.1007/s11033-021-06814-y] [PMID] [PMCID]
22. Ghaffari K, Falahati V, Motallebirad T, Safarabadi M, Tashakor AH, Azadi D. Microbiological and molecular study of paranasal sinus infections of children with malignancy and unknown origin fever in Markazi Province, Iran. Curr Therap Res. 2024;100:100745. [DOI:10.1016/j.curtheres.2024.100745] [PMID] [PMCID]
23. Monstein HJ, Östholm‐Balkhed Å, Nilsson M, Nilsson M, Dornbusch K, Nilsson L. Multiplex PCR amplification assay for the detection of blaSHV, blaTEM and blaCTX‐M genes in Enterobacteriaceae. Apmis. 2007;115(12):1400-8. [DOI:10.1111/j.1600-0463.2007.00722.x] [PMID] [PMCID]
24. Österblad M, Kirveskari J, Hakanen AJ, Tissari P, Vaara M, Jalava J. Carbapenemase-producing Enterobacteriaceae in Finland: the first years (2008-11). J Antimicrob Chemother. 2012;67(12):2860-4. [DOI:10.1093/jac/dks299] [PMID]
25. Ahmed AM, Nakano H, Shimamoto T. The first characterization of extended-spectrum β-lactamase-producing Salmonella in Japan. J Antimicrob Chemother. 2004;54(1):283-4. [DOI:10.1093/jac/dkh300] [PMID]
26. Feizabadi MM, Delfani S, Raji N, Majnooni A, Aligholi M, Shahcheraghi F, et al. Distribution of bla TEM, bla SHV, bla CTX-M genes among clinical isolates of Klebsiella pneumoniae at Labbafinejad Hospital, Tehran, Iran. Microb Drug Resist. 2010;16(1):49-53. [DOI:10.1089/mdr.2009.0096] [PMID]
27. Jalalvand K, Shayanfar N, Shahcheraghi F, Amini E, Mohammadpour M, Babaheidarian P. Evaluation of phenotypic and genotypic characteristics of carbapnemases-producing enterobacteriaceae and its prevalence in a referral hospital in Tehran city. Iran J pathol. 2020;15(2):86. [DOI:10.30699/ijp.2020.111181.2188] [PMID] [PMCID]
28. Kowalska-Krochmal B, Dudek-Wicher R. The minimum inhibitory concentration of antibiotics: Methods, interpretation, clinical relevance. Pathogens. 2021;10(2):165. [DOI:10.3390/pathogens10020165] [PMID] [PMCID]
29. Kumar M, Dutta R, Saxena S, Singhal S. Risk factor analysis in clinical isolates of ESBL and MBL (including NDM-1) producing Escherichia coli and Klebsiella species in a tertiary care hospital. J Clin Diag Res. 2015;9(11):DC08. [DOI:10.7860/JCDR/2015/15672.6766] [PMID] [PMCID]
30. Marie MA, John J, Krishnappa LG, Gopalkrishnan S. Molecular characterization of the β‐lactamases in Escherichia coli and Klebsiella pneumoniae from a tertiary care hospital in Riyadh, Saudi Arabia. Microbiol Immunol. 2013;57(12):805-10. [DOI:10.1111/1348-0421.12104] [PMID]
31. Armin S, Fallah F, Karimi A, Karbasiyan F, Alebouyeh M, Rafiei Tabatabaei S, et al. Antibiotic susceptibility patterns for carbapenem‐resistant enterobacteriaceae. Int J Microbiol. 2023;2023(1):8920977. [DOI:10.1155/2023/8920977] [PMID] [PMCID]
32. Akenten CW, Khan NA, Mbwana J, Krumkamp R, Fosu D, Paintsil EK, et al. Carriage of ESBL-producing Klebsiella pneumoniae and Escherichia coli among children in rural Ghana: a cross-sectional study. Antimicrob Resist Infect Control. 2023;12(1):60. [DOI:10.1186/s13756-023-01263-7] [PMID] [PMCID]
33. Kurittu P, Khakipoor B, Aarnio M, Nykäsenoja S, Brouwer M, Myllyniemi A-L, et al. Plasmid-borne and chromosomal ESBL/AmpC genes in Escherichia coli and Klebsiella pneumoniae in global food products. Front Microbiol. 2021;12:592291. [DOI:10.3389/fmicb.2021.592291] [PMID] [PMCID]
34. Shakib P, Ramazanzadeh R. Molecular epidemiology typing of blaOXA-48 and blaNDM-1 producing Klebsiella pneumoniae causing nosocomial infection. New Microbiol. 2023.
35. Zaman A, Sultan HM, Malik NUA, Waseem R, Farooq J. Characterization of blaNDM gene in multidrug-resistant pathogens. Int J Gen Pract Nurs. 2024;2(2):68-76. [DOI:10.26689/ijgpn.v2i2.7437]
36. Beig M, Badmasti F, Solgi H, Nikbin VS, Sholeh M. Carbapenemase genes distribution in clonal lineages of Acinetobacter baumannii: a comprehensive study on plasmids and chromosomes. Front Cell Infect Microbiol. 2023;13:1283583. [DOI:10.3389/fcimb.2023.1283583] [PMID] [PMCID]
37. Chatzidimitriou M, Tsolakidou P, Panagiota C, Mylona E, Mitka S. KPC-2 and VIM-1 producing Klebsiella pneumoniae ST39 high-risk clone isolated from a clinical sample in Volos, Greece. Acta Microb Immunol Hungarica. 2024;71(1):43-51. [DOI:10.1556/030.2024.02226] [PMID]
38. Li Y, Ma L, Ding X, Zhang R. Fecal carriage and genetic characteristics of carbapenem-resistant enterobacterales among adults from four provinces of China. Front Epidemiol. 2024;3:1304324. [DOI:10.3389/fepid.2023.1304324] [PMID] [PMCID]
39. Sivaraman GK, Rajan V, Vijayan A, Elangovan R, Prendiville A, Bachmann TT. Antibiotic resistance profiles and molecular characteristics of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae isolated from shrimp aquaculture farms in Kerala, India. Front Microbiol. 2021;12:622891. [DOI:10.3389/fmicb.2021.622891] [PMID] [PMCID]
40. Sajeev S, Hamza M, Rajan V, Vijayan A, Sivaraman GK, Shome BR,et al. Resistance profiles and genotyping of extended-spectrum beta-lactamase (ESBL)-producing and non-ESBL-producing E. coli and Klebsiella from retail market fishes. Infect Gene Evol. 2023;112:105446. [DOI:10.1016/j.meegid.2023.105446] [PMID]
41. Catalano A, Iacopetta D, Ceramella J, Scumaci D, Giuzio F, Saturnino C, et al. Multidrug resistance (MDR): A widespread phenomenon in pharmacological therapies. Molecules. 2022;27(3):616. [DOI:10.3390/molecules27030616] [PMID] [PMCID]
42. Tian X, Zheng X, Sun Y, Fang R, Zhang S, Zhang X, et al. Molecular mechanisms and epidemiology of carbapenem-resistant Escherichia coli isolated from Chinese patients during 2002-2017. Infect Drug Resist. 2020:501-12. [DOI:10.2147/IDR.S232010] [PMID] [PMCID]
43. Debabza M, Dziri R, Mechai A, Bouguessa A, Klibi N, Ouzari HI. Characterization of carbapenemase-producing Gram-negative bacilli: first report of blaNDM-1 in Enterobacter cloacae. J Infect Develop Count. 2023;17(09):1300-9. [DOI:10.3855/jidc.18031] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |